Glesatinib
|
|
Sicherheit
Glesatinib Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Glesatinib is a TKI that targets tumors with MET and AXL alterations.Clinical Use
Nonclinical models have shown glesatinib to be effective in MET exon 14 skipping mutations. It is currently being evaluated in phase II trials in NSCLC patients with MET alterations.Glesatinib Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Glesatinib Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 12)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 |
marketing@targetmol.com | United States | 32072 | 58 |
TargetMol Chemicals Inc. | +8613564774135 |
zijue.cai@tsbiochem.com | United States | 19863 | 58 |
Amadis Chemical Company Limited | 571-89925085 |
sales@amadischem.com | China | 131957 | 58 |
Sichuan Wei Keqi Biological Technology Co., Ltd. | 028-81700200 18116577057 |
3003855609@qq.com | China | 7887 | 56 |
Shanghai BetterBioChem Co., Ltd. | +86-18017644823 |
sales@betterbiochem.com | China | 325 | 58 |
TargetMol Chemicals Inc. | 4008200310 |
marketing@tsbiochem.com | China | 24648 | 58 |
Shanghai Tachizaki Biomedical Research Center | 18014399201 |
sales@chemlab-tachizaki.com | China | 2561 | 58 |
Nantong QuanYi Biotechnology Co., Ltd | 0513-66337626 18051384581 |
sales@chemhifuture.com | China | 4870 | 58 |
https://hanhongsci.com/ | 021-54306202 18917919676 |
info@hanhongsci.com | China | 29977 | 58 |
Sichuan Yiyan Pharmaceutical Research | 19949968070 |
2904199885@qq.com | China | 909 | 58 |
- Glesatinib
- Glesatinib (MGCD-265
- Benzeneacetamide, 4-fluoro-N-[[[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]amino]thioxomethyl]-
- 936694-12-1
- C31H27F2N5O3S2